Forschende haben dieses Prinzip aufgegriffen und weiterentwickelt, um CRISPR-Systeme für die Genomforschung und zunehmend ...
Gemeinsam mit dem Braunschweiger Helmholtz-Zentrum für Infektionsforschung (HZI) und der Utah State University (USU) in Logan ...
Team aus Würzburg, Braunschweig und den USA identifiziert Nuklease Cas12a3 mit präziser Funktionsweise | Aktuelle Studie in Nature ...
CRISPR/Cas-Systeme gelten als eine der Schlüsseltechnologien der Bioökonomie. Sie ermöglichen es, biologische Prozesse gezielt zu beeinflussen, beispielsweise ...
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
Crispr Therapeutics, in collaboration with Vertex, pioneered the first CRISPR-based gene therapy, Casgevy, with regulatory approval in multiple countries, poised for strong revenue growth from Q4 2024 ...
The coronavirus disease 2019 (COVID-19) pandemic was one of the most serious public health calamities in the last decade, causing global morbidity and mortality in the millions. The emergence of ...
Last August, KJ Muldoon was born with a potentially fatal genetic disorder. Just six months later, he received a Crispr treatment designed just for him. Muldoon has a rare disorder known as CPS1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback